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Abstract 
Background: Chronic obstructive pulmonary disease (COPD) and particularly emphysema are 
characterized by stiffness of the aorta, due in part to accelerated elastin degradation in the lungs 
and aorta. Stiffness of the pulmonary arteries (PA) may also be increased in COPD and 
emphysema due to loss of elastin but data are lacking. We assessed PA stiffness using magnetic 
resonance imaging (MRI) in patients with COPD and relate these measurements to COPD 
severity and percent emphysema.  
Methods and Results: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study 
recruited participants age 50-79 years with 10 or more packyears and free of clinical 
cardiovascular disease. COPD and COPD severity were defined on post-bronchodilator 
spirometry by ATS/ERS criteria. Percent emphysema was defined as the percentage of regions of 
the lung < -950 Hounsfield units on full-lung computed tomography.  Strain of the main, right 
and left PA was defined by the percent change in cross-sectional PA area between systole and 
diastole on cardiopulmonary MRI. Linear regression was used to adjust for demographics, body 
size, smoking and cardiac risk factors. Among 290 participants, PA strain was reduced in COPD 
compared to controls (P=0.002) and was inversely correlated with COPD severity (P=0.004).  
PA strain was inversely associated to percent emphysema on CT scan (P=0.01). PA strain was 
also markedly correlated with signs of right ventricular diastolic dysfunction.  
Conclusions:  PA strain is reduced in COPD, related in part to percent emphysema on CT scan, 
which may have implications for pulmonary small vessel flow and right ventricular function.  
Keywords: MR flowing imaging, Pulmonary artery, Strain, Lung function/COPD 
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Introduction 
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the 
United States
1
. COPD prevalence and mortality are increasing, particularly among women and 
minorities
2
. COPD is defined by accelerated, age-related loss in lung function resulting in 
incompletely reversible airway obstruction.  Emphysema partially overlaps with COPD and is 
defined by loss of lung architecture and parenchyma due, classically, to accelerated degradation 
of elastin in the lung.  Cigarette smoking is the primary cause of COPD and emphysema
3-5
 
although a minority of smokers develops these disorders.   
Various studies have noted that aortic stiffness, mainly assessed by carotid-femoral 
(aortic) pulse wave velocity using micromanometer applanation tonometry
6-8
, is abnormal in 
COPD and particularly in emphysema. Using this method, arterial stiffness was increased in 
COPD independent of cigarette smoking exposure
6
. The likely mechanism of this relationship is 
aberrant skin elastin degradation in the aorta
9
.   
Pulmonary artery (PA) elasticity is an important factor in smoothing the pulsatile flow 
from right ventricle (RV) to the steady flow in the smaller pulmonary vessels.  Pulmonary 
vascular wall stiffness is a significant contributor to RV afterload
10
 and increased PA stiffness 
has been documented in pulmonary hypertension using cardiac magnetic resonance imaging 
(CMRI) techniques
11, 12
.  The proximal PA and aorta have similar elastin content between 5
th
 and 
9
th
 decades
13
 hence it is likely that PA stiffness is increased in COPD as reported in aortic 
stiffness; however, no similar examination of the PA stiffness has been made in COPD in a large 
scale
14
, to our knowledge. 
We therefore hypothesized that elasticity of the main, right and left PA, measured by the 
strain (variations of the PA dimensions) using CMRI phase-contrast velocity mapping techniques 
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15, 16
, would be reduced in COPD, inversely associated with percentage of emphysema-like lung 
(hereafter referred to as percent emphysema) and inversely associated with measures of RV 
diastolic dysfunction.  
 
Methods  
Study Sample 
 The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study enrolled cases of 
COPD and controls predominantly from two prospective population-based cohort studies, 
MESA
17
 and the EMphysema and Cancer Action Project (EMCAP)
18
, who were age 50-79 years 
old with a 10 or more pack-year smoking history and who did not have clinical cardiovascular 
disease, stage IIIb-V kidney disease, asthma prior to age 45 years, other lung disease, prior lung 
resection, cancer, allergy to gadolinium, claustrophobia, metal in the body, pregnancy or weight 
> 300 lbs. We selected all eligible participants at four sites in the MESA Lung Study,
19
 over-
sampled  participants with COPD or emphysema from the remainder of MESA and from 
EMCAP, and selected a small number from the general outpatient community.  
 Protocols were approved by the institutional review boards of the participating 
institutions and the National Heart, Lung, and Blood Institute (NHLBI). Written informed 
consent was obtained from all participants.  
Spirometry  
Spirometry was conducted in accordance with American Thoracic Society/European 
Respiratory Society (ATS/ERS) guidelines
20
 on a dry-rolling-sealed spirometer (Occupational 
Marketing, Inc., Houston, TX) following the MESA Lung protocol
21
. COPD was defined as a 
post-bronchodilator ratio of the forced expiratory volume in 1 second (FEV1) to the forced vital 
capacity (FVC) < 0.70 following the ATS/ERS and GOLD definitions
22
. COPD severity was 
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classified as: mild, FEV1 ≥ 80% predicted; moderate, 50-80% predicted; and severe, FEV1 < 
50% predicted
22
. Predicted values were calculated using the Hankinson reference equations
23
 
with a 0.88 correction for Asians
21
. 
Percent of Emphysema-Like Lung 
All participants underwent full-lung CTs on 64-slice helical scanners following the 
MESA-Lung/SPIROMICS full-inspiration protocol (0.984 pitch, 0.5 seconds, 120 kVp)
24
. The 
milliamperes (mA) for MESA participants was based on body mass index (BMI): 145 for <20 
kg/m
2
, 180 for 20-30 kg/m
2
 and 270 for >30 kg/m
2
, and was set at 200 for non-MESA 
participants. Images were reconstructed at 0.625 mm. Image attenuation was assessed using 
APOLLO software (VIDA Diagnostics, Coralville IA) at a single reading center by trained 
readers without knowledge of other participant information. Percent emphysema was defined as 
the percentage of total voxels within the lung field that fell below -950 Hounsfield units. 
Magnetic Resonance Imaging 
All participants were imaged using one of four 1.5T whole-body MRI systems (Signa 
LX, GE Healthcare, Waukesha, Wisconsin; Avanto or Espree, Siemens Medical Systems, 
Erlangen, Germany) with a phased-array coil for signal reception placed around the thorax with 
anterior and posterior elements selected around the heart. To determine the planes needed for the 
short axis images, electrocardiogram-gated, cardiac four-chamber and two-chamber view cine 
steady state free precession sequences were performed. Participants were instructed to hold their 
breath in expiration during imaging. To measure ventricular function, the entire heart was 
imaged in short-axis orientation with 12 or more slices. All cine images had an acquired 
temporal resolution of 48 msec, retrospectively reconstructed as 40 cine frames at 20–35 msec 
intervals over the cardiac cycle.  Left ventricular heart function including myocardial mass, 
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volume, stroke volume, cardiac output, and ejection fraction was measured through contouring 
of the left ventricle. 
To determine the planes needed for main PA images, we used an oblique localizer 
prescribed from axial and coronal images to visualize the natural curvature of the main 
pulmonary artery. For the main PA strain measurement, an imaging plane above the pulmonary 
valve but below the pulmonary bifurcation was used. The right PA was imaged in cross-section 
between the trachea and the ascending aorta.  The left PA was prescribed close to the pulmonary 
trunk to avoid left upper lobe artery. Phase-contrast images were obtained using a segmented fast 
gradient echo sequence (repetition time 7.5 ms, echo time 3.1 ms, slice thickness 8 mm, matrix 
256×256, 2 segments, time per acquired cine frame 30 ms, reconstructed by the retrospective 
gating software as 30 cardiac phases over the cardiac cycle, two averages, velocity encoding 100 
cm/s) without breath hold. Strain of the PA was measured from the largest systolic and the 
smallest diastolic areas derived from the magnitude images by the following formula, 
100×(maximum area – minimum area)/minimum area.  Thirty studies were randomly selected 
for inter-reader variability. The coefficient of variation of main PA strain was 0.06. 
The same phase-contrast protocol was used to measure blood flow across the tricuspid 
and mitral valves for determination of the right and left ventricular filling. The resulting biphasic 
diastolic inflow pattern consists of two peaks, representing the early filling phase and the atrial 
contraction. Analysis of the early filling phase and the atrial contraction was performed by 
calculating their peak filling rates and ratio of the peak filling rates (E/A). All phase-contrast 
images were analyzed quantitatively using dedicated software (QFLOW 7.2, Medis, Leiden, The 
Netherlands), and CIM (Cardiac Imaging Modeling, the University of Auckland, New Zealand) 
for the cardiac function. CMRI readers were blinded from other participant information. 
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DLco and Plethysmography 
 Single-breath DLco was measured for a subset of participants with a Sensormedics 
Autobox 220 Series instrument (Viasys Healthcare, Yorba Linda, CA) following ATS/ERS 
guidelines
25
. The average of all acceptable tests (minimum of two tests) was reported. Breath-
hold time was assessed by the method of Jones and Meade
26
.  
Body plethysmography was performed for a subset of participants using a V6200 Series 
Autobox (Sensormedics, Yorba Linda, CA) following ATS/ERS recommendations
27
. Predicted 
lung volumes were calculated from Crapo questions for patients under 65 years and Garcia-Rio 
equations for patients 65 years and older
28, 29
. Residual lung volume (RLV) was defined as the 
volume of gas remaining in the lung after maximal exhalation, while total lung capacity (TLC) 
was defined as the volume of gas in the lungs after maximal inspiration. 
Covariates 
Age, gender, race/ethnicity, educational attainment, pack-years, and medical history were 
self-reported. Medication use was assessed by medication inventory
30
. Height, weight and blood 
pressure were measured following standardized MESA protocols
31
. Participants with a blood 
cotinine level greater than 25 ng/mL, or a urine level greater than 500 ng/mL or a self- report of 
current smoking were classified as current smokers. Oxygen saturation was measured by pulse 
oximeter, off oxygen. Glucose, total cholesterol and high-density lipoprotein (HDL) levels and 
complete blood counts were measured from blood samples after a twelve-hour fast. Low-density 
lipoprotein (LDL) level was calculated using the Friedewald equation
32
. 
 Diabetes was defined as a fasting plasma glucose≥126 mg/dL or a self-report of 
physician diagnosis. Hypertension was defined as systolic blood pressure (SBP)≥140 mmHg, 
diastolic blood pressure (DBP)≥90 mmHg or physician diagnosis
33
. 
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Statistical Analysis  
 The cohort was stratified by the presence and severity of COPD.  Initial analyses used 
multivariable regression to assess the association of cardiovascular risk factors with PA strain 
adjusted for age, sex, race/ethnicity, height and weight.  
For the main analyses, we first used mixed effects models with random slopes and 
intercepts to examine the relationships of the strain using measurements from all three PAs with 
COPD endpoints of interest in order to assess overall PA strain and to account for multiple 
comparisons. If the mixed effects model yielded a statistically significant result, we then 
examined each PA individually.  The base model (model 1) was adjusted for age, gender, height, 
weight, race/ethnicity and cohort of selection, and the full model (model 2) was additionally 
adjusted for smoking status, pack-years, diabetes mellitus, hypertension, oxygen saturation, 
LDL, HDL and statin use.  
 Given that the study was recruited based upon COPD status rather than as a cohort study, 
continuous analyses (e.g., for percent emphysema) were weighted proportionate to the inverse 
ratio of the sample prevalence to the source study prevalence.  COPD cases recruited from the 
outpatient community were assigned the same weights as cases from EMCAP. The Pearson 
correlation coefficient (r) and unadjusted linear regression analysis were used to examine the 
association between pulmonary strain and diastolic function.  Sensitivity analyses were 
performed without weighting. Statistical significance was defined by a two-tailed P-value<0.05. 
Analyses were performed in SAS 9.2 (Cary, NC and R version 2.14.1 Vienna, Austria).   
Results 
The study sample included 290 participants with complete spirometry, CT and main PA 
MR strain measurements. The mean age was 68.4±6.6 years and 47% had COPD (40% mild, 
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48% moderate and 12% severe). Fifty nine percent were men. Twenty seven percent smoked 
currently and the median pack-years was 33. The race/ethnic distribution was 56% Non-Hispanic 
white, 25% African-American, 13% Hispanic and 6% Chinese-American.  
The characteristics of the study sample, stratified by COPD severity, are shown in Table 
1. Participants with more severe COPD were more likely to be male, Non-Hispanic white and 
have greater pack-years.  
Pulmonary Artery Strain and Cardiac Risk Factors 
Table 2 displays the individual partial correlation coefficient and P value of each 
parameter in multivariable analysis adjusted for age, sex, race, height, and weight. Strain of all 
PA was significantly decreased in current smokers. Higher DBP was inversely correlated to main 
PA strain and diabetes was associated with left PA strain.  
Pulmonary Artery Strain and COPD  
 PA strain was reduced in COPD of all categories compared to controls in the fully 
adjusted mixed model (P=0.002).  Strain of the main PA was reduced in COPD compared to 
controls in the fully adjusted model (mean difference, -1.59%; 95% CI -3.10, -0.08: P=0.04), as 
was strain of the right and left PA (P=0.01 and P<0.001), respectively.   
 PA strain was also reduced across categories of COPD severity in the fully adjusted 
mixed model (P=0.004).  The association of COPD severity and main PA strain was slightly 
attenuated in the full model but those for right and left PA strain were robust (Table 3). 
Pulmonary Strain and Percent Emphysema  
PA strain was inversely related to percent emphysema in the fully adjusted mixed model 
(P=0.01).  The significance of this association varied somewhat by vessel (Table 4).  Figure 1 
shows the relationship of the continuous measures of percent emphysema and right PA strain in 
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the fully adjusted model. Right PA strain decreased quickly and plateaued as percent emphysema 
increased.  
PA Strain and Measures of Diastolic Dysfunction 
Diastolic function assessed by ventricular flow E/A ratio was performed in a subset of 
194 subjects.  PA strain was significantly related to measures of RV and LV diastolic function in 
the univariable analyses. Pearson correlations between main, right and left PA strain and RV E/A 
ratio were 0.67, 0.45 and 0.36, respectively (all P<0.001). Figure 2 demonstrates a significant 
positive correlation between main PA strain and RV E/A ratio. Similar correlations also existed 
between main, right and left PA strain and LV E/A ratio (Pearson correlation r=0.37, 0.45 and 
0.25, respectively, all P<0.001). However, only RV E/A ratio was significantly related to PA 
distensibiity in the fully adjusted mixed model (P=0.02). 
 Both RV and LV E/A ratios in COPD were impaired compared to controls, but these 
differences did not attain statistical significance. 
Pulmonary Strain and Hyperinflation 
In contrast to findings for COPD and percent emphysema, there was little evidence for an 
association between PA strain with diffusing capacity or measures of pulmonary hyperinflation 
in the subset with available measures (Supplemental Table 1). 
Sensitivity Analyses 
Similar associations for strain and COPD were observed in analyses additionally adjusted 
for systolic and diastolic blood pressure, LV stroke volume, LV end diastolic volume and mass, 
white blood cell (WBC) count and cardiac output (Figure 3). The results also did not change 
after restriction of the sample to MESA and EMCAP cohorts, former smokers, white 
participants, and those without diabetes or sleep apnea. The association between right PA strain 
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and COPD was greater among participants with hypertension and attenuated among participants 
without hypertension (interaction P-value=0.02), although additional adjustment systolic blood 
pressure and diastolic blood pressure (in addition to hypertension) had no impact on the results 
(Figure 3).  
 
Discussion 
In this relatively large MRI study of predominantly mild-moderate COPD, PA strain was 
independently reduced in COPD and was inversely associated with severity of COPD and 
percent emphysema on CT scan. These findings are important to cardiopulmonary function as 
PA stiffening affects pulmonary blood flow
34
, reduces functional capacity
35
, and is a significant 
contributor to increased right ventricular afterload.
10
. 
In a study by Vonk-Noordegraaf et al.
14
, right PA strain was examined in 25 COPD 
patients with mild hypoxemia, and no difference was found compared to age-matched controls. 
However, our results are consistent with prior work in pulmonary arterial hypertension, which 
demonstrated similar findings
12, 16, 22, 36
. Using MRI methods, Sanz et al.
12
 showed increased PA 
stiffness in patients with pulmonary hypertension at rest in comparison with those with exercise-
induced or no pulmonary hypertension. Another study by Lau and co-workers
36
 also reported 
increased stiffness in the proximal elastic PA in patients with pulmonary hypertension using 
intravascular ultrasound.  
Our findings are also consistent with several prior studies of aortic stiffness in COPD.  
Mills et al.
8
 reported that patients with COPD had increased arterial stiffness compared with 
matched controls assessed as elevated augmentation pressures and a reduced time to wave 
reflection. McAllister et al.
7
 showed that arterial stiffness was increased with emphysema 
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severity in patients with COPD. On the other hand, there was no association between proximal 
aortic strain measured by MRI phase contrast images and pulmonary function or percent 
emphysema in the larger MESA Lung Study
37
. 
A likely mechanism underlying both PA and aortic stiffness in COPD and emphysema is 
loss of elastin in the lungs and the major vessels.  Abnormal elastin degradation is clearly 
described in emphysema pathogenesis
38, 39
 and systematic elastin degradation outside of the lung 
in COPD was demonstrated by Maclay et al.,
9
 who showed enhanced skin elastin degradation in 
COPD patients compared with controls and was in association with emphysema severity and 
carotid-femoral pulse wave velocity. Other COPD-related effects on the vasculature are also 
possible, including systematic inflammation, which is elevated in COPD
40
 and correlates with 
aortic pulse wave velocity
41
.  
PA strain was quite highly correlated with RV E/A ratio, which suggests that PA stiffness 
may contribute to RV diastolic dysfunction in COPD.  Similar observations have been observed 
for aortic compliance and left ventricular diastolic dysfunction in a community-based cohort 
study
42
,  in type 2 diabetes mellitus
43
, and in hypertensive hearts
44
. Vascular stiffness expresses 
opposition to steady flow. However, for the complete description of the RV-PA interaction, 
pulsatile properties, which are expressed by PA input impedance spectrum, must be taken into 
account. Characteristic PA input impedance was elevated in pulmonary hypertension and cor 
pulmonale patients
4, 15, 45
. Reduced pulmonary strain increases the impedance to outflow from the 
right ventricle and contribute as much as 30% to 40% of the increase in load to which the right 
ventricle is exposed
46
. It has been hypothesized that this increase in stiffness, which is associated 
with vascular remodeling in the proximal vessel, might be initiated by endothelial dysfunction in 
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COPD
47
 and leads to obstruction of the delivery of blood flow from right ventricle and ultimately 
results in a loss of pulmonary flow during diastole. 
An unexpected finding was that the association of COPD with right PA distensiblity was 
modified by hypertension.  This was not explained by a possible treatment effect of 
antihypertensive drugs (data not shown) and may be a false positive finding. Possible 
explanations include hypertension being a marker for stiffness of the entire vascular system, with 
increased susceptibility to PA stiffness, endothelial dysfunction affecting both the systemic and 
pulmonary vasculature, or transmitted increased LV afterload. The last of these seems unlikely 
given the lack of change with adjustment for LV parameters. 
The major limitation of this study is that cardiac catheterization was not performed in 
these patients. However, we did not expect participants with severe pulmonary hypertension in 
this study because patients who have clinical cardiovascular disease were excluded in the 
recruitment. Even though a large number of participants were examined in the study, the sample 
size of severe COPD was relatively small; hence, it is possible (although in our opinion unlikely) 
that the results may not apply to very severe COPD. 
Results were generally consistent for main, right and left PA but were weaker and more 
marginal for the main PA. This is likely due to greater variability in the assessment of the main 
PA, the tortuous course of which makes standardization of reading more challenging. 
We conclude that patients with COPD but without overt cardiovascular disease show 
increased PA stiffness, which is also related to percent emphysema on CT scan.  The functional 
implications of this finding relate to RV load, and pulmonary strain was strongly related to the 
RV diastolic function. 
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Figure Legends 
 
Figure 1. Multivariable relationship between right pulmonary artery strain and percent 
emphysema 
Tick marks above the x-axis represent observed emphysema measures. The predicted change in 
PA strain is represented by the dark line and was obtained from a smoothed regression model 
adjusted for age, race, gender, height, weight, cohort, smoking status, pack years, educational 
attainment, diabetes mellitus, hypertension, oxygen saturation, LDL, HDL, statin use and high 
mAs. 
 
Figure 2. Main pulmonary artery strain and E/A ratio of the right ventricle. 
Main PA strain was significantly correlated to RV E/A ratio. 
 
Figure 3. Sensitivity analysis of right pulmonary artery strain with COPD status.  
Predicted mean difference in base model adjusted for age, gender, race/ethnicity, cohort, 
smoking status, pack-years, height, weight, diabetes mellitus, hypertension, oxygen saturation, 
white blood cell count, sleep apnea, HDL and statin use. Inclusion of co-variate, population 
subset, or dependent variable indicated.  
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Table 1.  Clinical characteristics of participants in the MESA COPD Study with main strain stratified by COPD severity.  
    COPD   
 Controls 
(n=155)  
 Mild  
(n=54) 
Moderate 
(n=65) 
Severe/Very Severe 
(n=16) 
Age, mean±SD, years 67.95±6.55 70.15±6.25 67.80±7.36 68.75±5.90 
Sex, male, No. (%) 83 (53.55) 41 (75.93) 38 (58.46) 10 (62.50) 
Race/ethnicity   
White, No. (%) 74 (47.74) 37 (68.52) 39 (60.00) 12 (75.00) 
African American, No. (%) 36 (23.23) 12 (22.22) 19 (29.23) 4 (25.00) 
Other, No. (%) 45 (29.03) 5 (9.26) 7 (10.77) 0 (0.0) 
Educational attainment 
≤ High school degree, No. (%) 39 (25.16) 11 (20.37) 15 (23.08) 3 (18.75) 
Some college/Assoc. degree/ Vocational 
school, No. (%) 
 
52 (33.55) 12 (22.22) 14 (21.54) 5 (31.25) 
≥ College degree, No. (%) 
64 (41.29) 31 (57.41) 36 (55.38) 8 (50.00) 
Height, mean±SD, cm 167.11±9.52 172.18±7.66 170.37±9.64 169.61±11.52 
Weight, mean±SD, kg 80.39±16.97 79.33±15.25 79.73±18.38 80.70±24.85 
Body mass index, mean±SD, kg/m
2
 28.66±4.96 26.63±3.98 27.29±5.09 27.56±6.21 
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Cigarette smoking status 
Former, No. (%) 121 (78.06) 41 (75.93) 39 (60.00) 12 (75.00) 
Current, No. (%) 34 (21.94) 13 (24.07) 26 (40.00) 4 (25.00) 
Pack-years of smoking, median (IQR) 27.0 (17.7, 43.5) 34.3 (25.0, 60.0) 39.6 (25.5, 51.8) 46.3 (22.5, 62.3) 
LDL, mean±SD, mg/dL  109.93±32.05 104.15±30.84 96.71±29.20 100.31±41.82 
HDL, mean±SD, mg/dL  54.84±17.15 58.57±17.62 59.14±19.64 54.56±20.98 
Statin, No. (%)  52 (33.55) 25 (46.30) 31 (47.69) 5 (31.25) 
Systolic blood pressure, mean±SD, mmHg 119.91±18.73 120.49±16.66 123.78±16.30 128.59±12.89 
Diastolic blood pressure, mean±SD, mmHg 69.61±9.36 70.30±9.06 71.61±8.99 74.84±8.82 
Hypertension, No. (%)  65 (41.94) 23 (42.59) 32 (49.69) 7 (43.75) 
Fasting Plasma Glucose, median (IQR),mg/dL 96 (91.0, 105.0) 96 (88.0, 107.0) 100 (93.0, 105.0) 93 (83.5, 107.0) 
Diabetes Mellitus, No. (%) 24 (15.48) 5 (9.26) 9 (13.85) 4 (25.00) 
FEV1 percent of predicted, mean±SD  101.26±15.64 92.15±9.61 68.58±8.29 39.56±7.54 
FVC percent of predicted, mean±SD  98.11±15.14 107.25±12.62 90.70±12.93 73.78±14.86 
FEV1/FVC ratio, mean±SD, %  0.78±0.05 0.64±0.05 0.58±0.09 0.40±0.08 
DLco % predicted, mean±SD, %, n=106 68.15±10.62 62.77±11.27 54.45±14.50 40.90±10.48 
DLco VA % predicted, mean±SD, %, n=106 79.42±13.11 67.76±10.63 68.79±19.46 61.07±15.40 
RLV % predicted, mean±SD, %, n=106 71.33±18.05 81.47±17.78 97.64±29.57 138.01±36 
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RLV/TLC ratio, mean±SD, %, n=106 0.32±0.07 0.30±0.06 0.39±0.08 0.52±0.08 
Percent Emphysema-950, median (IQR) 1.26 (0.59, 2.85) 3.36 (1.84, 8.18) 3.50 (1.33, 7.93) 16.56 (7.15, 24.80) 
Oxygenation Saturation, mean±SD, %  99.94±49.43 95.90±4.70 96.16±3.85 95.90±2.03 
Sleep Apnea, self-reported, No (%) 10 (6.45) 2 (3.70) 7 (10.77) 3 (18.75) 
Left Ventricle E/A ratio, mean±SD,  n=194 0.93±0.28 0.88±0.29 0.92±0.41 0.88±0.26 
Right Ventricle E/A ratio, mean±SD,  n=194  0.83±0.39 0.81±0.34 0.75±0.29 0.73±0.33 
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Table 2.  The association of cardiac risk factors and pulmonary artery (PA) strain in the MESA COPD Study.  
 
 
 
 
 
Main PA 
Strain (%)* 
Right PA 
 
Left PA 
Smoking status -0.182 (0.002) -0.216 (<0.001) -0.216 (<0.001) 
Diabetes -0.061 (0.30) -0.087 (0.16) -0.166 (0.007) 
Fasting Plasma Glucose -0.069 (0.25) -0.084 (0.18) -0.125 (0.043) 
Hypertension 0.067 (0.26) -0.062 (0.32) -0.052 (0.40) 
Systolic blood pressure -0.053 (0.37) -0.036 (0.56) -0.009 (0.88) 
Diastolic blood pressure -0.159 (0.008) -0.139 (0.02) 0.068 (0.27) 
Hypercholestrolemia -0.030 (0.62) -0.054 (0.38) 0.012 (0.84) 
Low Density Lipoprotein 0.011 (0.86) -0.059 (0.34) 0.015 (0.81) 
High Density Lipoprotein  0.055 (0.36) 0.074 (0.23) 0.76 (0.22) 
 
* Partial coefficients (P-value, bold for P<0.05) from correlation coefficients adjusted for age, sex, race, height, and weight. 
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Table 3.  Predicted mean difference of pulmonary artery strain in the MESA COPD Study by COPD severity. 
 
*p < 0.05 
Model 1 adjusted for age, race, gender, height, weight, and cohort 
Model 2 adjusted for variables in model 2 in addition to smoking status, pack years, educational attainment, diabetes mellitus, 
hypertension, oxygen saturation, LDL, HDL and statin use. 
 
 Controls Mild Moderate Severe P-Trend 
 n=155 n=54 n=65 n=16  
Strain of main PA, %  
Model 1, mean difference Reference -1.49 -1.44 -2.78 0.04 
Model 1, predicted mean 15.41 13.92 13.97 12.63  
Model 2, mean difference Reference -1.48 -1.44 -2.56 0.08 
Model 2, predicted mean 15.40 13.92 13.96 12.84  
 n=143 n=50 n=62 n=14  
Strain of right PA, %   
Model 1, mean difference Reference -0.58 -3.30* -3.83 0.005 
Model 1, predicted mean 20.59 20.01 17.29 16.76  
Model 2, mean difference Reference -0.93 -3.62* -3.85 0.01 
Model 2, predicted mean 20.67 19.74 17.05 16.82  
Strain of left PA, %   
Model 1, mean difference Reference -4.17* -3.34* -4.08 0.002 
Model 1, predicted mean 18.26 14.09 10.75 14.18  
Model 2, mean difference Reference -4.63* -3.33* -2.66 0.003 
Model 2, predicted mean 18.25 13.62 14.92 15.59  
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Table 4.  Predicted mean levels of pulmonary artery strain in the MESA COPD Study by percent emphysema. 
 
 
Percent Emphysema Difference per 
log increase in 
percent 
emphysema  
[95% CI] 
P-value 
quintile 1 
(n=58) 
  
quintile 2 
 (n=56) 
quintile 3 
(n=58) 
quintile 4 
(n=57) 
 quintile 5 
(n=58) 
Strain of main PA 
Model 1,* predicted value 
 
15.40 14.92 14.63 14.34 13.86 -0.44 
(-1.13, 0.25) 
0.21 
Model 2,† 16.03 15.29 14.86 14.41 13.68 -0.67 
(-1.33, -0.01) 
0.049 
 (n=53) (n=53) (n=53) (n=54) (n=53)   
Strain of right PA   
Model 1, predicted value 
 
23.01 22.00 21.40 20.77 19.77 -0.92 
(-1.92, 0.098) 
0.07 
Model 2 
 
21.84 20.54 19.77 18.97 17.69 -1.18 
(-2.50, -0.26) 
0.01 
Strain of left PA   
Model 1, predicted value 
 
19.47 19.16 18.98 18.79 18.49 -0.28 
(-1.18, 0.63) 
0.55 
Model 2 
 
18.35 17.65 17.23 16.80 16.10 -0.64 
(-1.51, 0.24)  
0.15 
Model 1 adjusted for age, race, gender, height, weight, and cohort 
Model 2 adjusted for variables in model 2 in addition to smoking status, pack years, educational attainment, diabetes mellitus, 
hypertension, oxygen saturation, LDL, HDL, statin use and mAs. 
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Figure 1. Multivariable relationship between right pulmonary artery strain and percent emphysema.  
Tick marks above the x-axis represent observed emphysema measures. The predicted change in PA strain is 
represented by the dark line and was obtained from a smoothed regression model adjusted for age, race, 
gender, height, weight, cohort, smoking status, pack years, educational attainment, diabetes mellitus, 
hypertension, oxygen saturation, LDL, HDL, statin use and high mAs.  
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Figure 2. Main pulmonary artery strain and E/A ratio of the right ventricle.  
Main PA strain was significantly correlated to RV E/A ratio.  
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Figure 3. Sensitivity analysis of right pulmonary artery strain with COPD status.  
Predicted mean difference in base model adjusted for age, gender, race/ethnicity, cohort, smoking status, 
pack-years, height, weight, diabetes mellitus, hypertension, oxygen saturation, white blood cell count, sleep 
apnea, HDL and statin use. Inclusion of co-variate, population subset, or dependent variable indicated.  
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